EXTH-06. CD38-TARGETED THERAPY IN GLIOBLASTOMA

BACKGROUND: Glioblastoma (GBM) remains a malignancy with a dismal prognosis in spite of current optimal management, including maximal resection, radiation therapy, and alkylating chemotherapy. Relapse is inevitable with the paucity of further effective therapies. The development of novel targeted th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Aulakh, Sonikpreet, Manna, Alak, Schiapparelli, Paula, Ailawadhi, Sikander, Paulus, Aneel, Rosenfeld, Steven, Quinones-Hinojosa, Alfredo, Chanan-Khan, Asher
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216983/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.355
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados